mFOLFOX6 + cetuximab

DRUG2 trials

Sponsors

National Cancer Center Hospital East, Fudan University

Conditions

Colorectal CancerLiver MetastasesMetastatic colorectal cancer

Phase 2

Feasibility study of neoadjuvant mFOLFOX6 plus cetuximab in patients with resectable liver limited metastases from colorectal cancer harboring KRAS wild type

Active, not recruitingJPRN-UMIN000007545

National Cancer Center Hospital EastMetastatic colorectal cancer

Start: 2012-03-01Target: 20Updated: 2025-07-18

Phase 3

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Not yet recruitingNCT05948072

Fudan UniversityColorectal Cancer, Liver Metastases

Start: 2023-07-15End: 2026-07-15Target: 250Updated: 2023-07-17